These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38488757)

  • 1. Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
    Green AR; Quiles R; Daddato AE; Merrey J; Weffald L; Gleason K; Xue QL; Swarthout M; Feeser S; Boyd CM; Wolff JL; Blinka MD; Libby AM; Boxer RS
    J Am Geriatr Soc; 2024 Jul; 72(7):1973-1984. PubMed ID: 38488757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of: Pharmacist-driven deprescribing initiative in primary care.
    Rea E; Portman D; Ioannou K; Lumley B
    J Am Pharm Assoc (2003); 2024; 64(4S):102162. PubMed ID: 39127936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.
    Lüthold RV; Cateau D; Jenkinson SP; Streit S; Jungo KT
    BMC Health Serv Res; 2024 Jul; 24(1):849. PubMed ID: 39061037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
    Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
    J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of a pilot pharmacist-led hospice deprescribing program initiative.
    Le V; Patel N; Nguyen Q; Woldu H; Nguyen L; Lee A; Deguzman L; Krishnaswami A
    J Am Geriatr Soc; 2021 May; 69(5):1370-1376. PubMed ID: 33772752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-driven deprescribing initiative in primary care.
    Rea E; Portman D; Ioannou K; Lumley B
    J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-Led Deprescribing for Patients With Polypharmacy and Chronic Disease States: A Retrospective Cohort Study.
    Chan M; Plakogiannis R; Stefanidis A; Chen M; Saraon T
    J Pharm Pract; 2023 Oct; 36(5):1192-1200. PubMed ID: 35522029
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
    Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
    Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.
    Growdon ME; Hunt LJ; Miller MJ; Halim M; Karliner LS; Gonzales R; Sudore RL; Steinman MA; Harrison KL
    J Gen Intern Med; 2024 Oct; 39(13):2461-2470. PubMed ID: 38941059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study.
    Green AR; Boyd CM; Gleason KS; Wright L; Kraus CR; Bedoy R; Sanchez B; Norton J; Sheehan OC; Wolff JL; Reeve E; Maciejewski ML; Weffald LA; Bayliss EA
    J Gen Intern Med; 2020 Dec; 35(12):3556-3563. PubMed ID: 32728959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
    Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
    Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
    Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
    BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.